Rowe, Jacob M <br/><br/>
Progress and predictions: AML in 2018.  [electronic resource] 

 -  Best practice & research. Clinical haematology  12 2018 
 - 337-340 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-1924 
<br/><br/><label>Standard No.: </label>10.1016/j.beha.2018.09.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Approval<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Isocitrate Dehydrogenase--antagonists & inhibitors<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Neoplasm, Residual<br/>Protein Kinase Inhibitors--therapeutic use<br/>United States<br/>United States Food and Drug Administration<br/>fms-Like Tyrosine Kinase 3--antagonists & inhibitors